In Case You Missed In It: News On FDA’s Foreign Offices, Decentralized Clinical Trials, And More

15 Jan 2024

• By Pink Sheet Team

We clean out your MLK Day inbox so you don’t have to.

While our US staff used the Martin Luther King, Jr. holiday to relax, reflect, and give back to our community, the Pink Sheet’s global team continued to deliver insights about the pharmaceutical industry. Below are the stories that went out in the Monday email in case you missed them:

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

19 Sep 2024

• By Neena Brizmohun

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

16 Sep 2024

• By Nielsen Hobbs

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

04 Sep 2024

• By Nielsen Hobbs

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

18 Jul 2024

• By Francesca Bruce

A new pilot aims to take Brazil closer to ‘digital transformation.’

Brazil’s ANVISA Clarifies Registration Procedures For Biologicals

24 Apr 2025

• By Francesca Bruce

Brazil’s drug regulator has published a new technical note updating guidelines on registration and post-registration procedures for biological products.